Month: March 2020
-
Phone App Tracking Covid-19 Symptom Reports
A smartphone app is collecting individual reports about Covid-19 symptoms and other health conditions to provide earlier warnings of outbreaks to health authorities.
-
Start-Up Licenses Immunotherapies in $880M Deal
A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company.
-
Biotechs Explore Cell Therapy for Covid-19 Antibodies
Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections.
-
![Simple, Inexpensive Ventilator Developed [Updated]](https://technewslit.com/sciencebusiness/wp-content/uploads/2020/03/ApolloBVM_JeffFitlow_RiceUniv-150x100.jpg)
Simple, Inexpensive Ventilator Developed [Updated]
An engineering team created a simple automated ventilator with easy-to-make and available parts to help people in respiratory distress keep breathing.
-
Infographic – U.S. Covid-19 Tests, Backlog Grow
The number of new Covid-19 tests per day in the U.S. now exceeds 100,000, but the backlog of tests awaiting results has grown with it.
-
Prescription Insomnia App Okayed by FDA
A mobile app prescribed by physicians to treat chronic insomnia is cleared by the Food and Drug Administration for marketing in the U.S.
-
Sanofi, Biotech Partner on RNA Covid-19 Vaccine
Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections
-
Business-Academic A.I. Research Network Formed
Two companies, including Microsoft Corp., and several research universities plan to study artificial intelligence for digitally transforming government and business.
-
Smart Watches Enlisted to Detect Viral Outbreaks
A research institute is asking people with smart watches and activity trackers to donate their data to find early signs of viral disease outbreaks, like Covid-19.
-
Consortium to Find Neutralizing Viral Antibodies
A coalition of business and academic labs is creating a process to quickly identify antibodies in blood samples that neutralize viruses like SARS-CoV-2.